Podcast
MSL Talk: Tom Caravela, Greg Auclair
Emotional Intelligence and why it is important for MSLs with Jessica Freund
Summary
In this episode, Jessica Freund from Biogen shares her journey into the pharmaceutical industry, highlighting her transition from Sanofi and her current role. The discussion delves into the significance of emotional intelligence for Medical Science Liaisons (MSLs), exploring its definition, teachability, and impact on career progression. Jessica provides insights on evaluating emotional intelligence during interviews and offers strategies for aspiring MSLs to navigate challenges and feedback. The conversation emphasizes the critical role of networking in career development. The episode concludes with Jessica's key advice and a call to action for listeners.
Today’s guest is Jessica Freund. Jessica is the Field Medical Director- Alzheimer’s Disease at Biogen. Our discussion is about emotional intelligence for MSLs and MSLs career development.
In this episode:
- Getting into the first job in the industry
- What is Emotional Intelligence
- Why is it important for MSLs to have emotional intelligence
- How does the application of emotional intelligence create opportunities
- Ways MSLs can strengthen their emotional intelligence
- What questions might be asked during interview that would help determine whether or not a person has a level of emotional intelligence
- Advice to those who really wanted to get into their first MSL role
Emotional Intelligence for MSLs, Medical Science Liaison career, Networking in pharmaceutical industry, Evaluating emotional intelligence, MSL interview strategies
Related Topics
You May Also Like
MSL Talk: Tom Caravela, Greg Auclair
Podcast
MSL Talk: Tom Caravela, Dr. Tanya Johnson
An Unexpected Journey From Novice MSL to Global Medical Excellence Leader with Tonya Johnson
Article
Kushal T. Kadakia, MSc, Malke Asaad, MD, Erica Adlakha, MS, Michael J. Overman, MD, Cristina M. Checka, MD, and Anaeze C. Offodile II, MD, MPH
Virtual Clinical Trials in Oncology-Overview, Challenges, Policy Considerations, and Future Directions
Article
Emmanuelle Jacqueta, Ghania Kerouani-Lafayeb, Francoise Grudeb, Sergio Goncalvesb, Annie Lorenced, Florence Turcryb, Liora Brunelb, Laetitia Belgodereb, Adrien Monardc, Gaëlle Guyaderb, Lotfi Boudalib, Nicolas Albin
Comparative study on anticancer drug access times between FDA, EMA and the French temporary authorisation for use program over 13 years
Article
Aaron S. Long, BS; Audrey D. Zhang, MD; Caitlin E. Meyer, MLIS; Alexander C. Egilman, BS; Joseph S. Ross, MD, MHS; Joshua D. Wallach, PhD, MS
Evaluation of Trials Comparing Single-Enantiomer Drugs to Their Racemic Precursors: A Systematic Review
Article
iNIZIO